메뉴 건너뛰기




Volumn 14, Issue 5, 2015, Pages 625-632

Feedback for patients reporting adverse drug reactions; Satisfaction and expectations

Author keywords

Adverse drug reactions; Feedback; Patient reporting; Pharmacovigilance

Indexed keywords

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; FEEDBACK SYSTEM; FEMALE; HUMAN; LIKERT SCALE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT SATISFACTION; PERSONAL EXPERIENCE; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; ADOLESCENT; MIDDLE AGED; NETHERLANDS; ORGANIZATION AND MANAGEMENT; YOUNG ADULT;

EID: 84928309905     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2015.1021775     Document Type: Article
Times cited : (10)

References (20)
  • 1
    • 84857174073 scopus 로고    scopus 로고
    • Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands
    • Oosterhuis I, van Hunsel F, van Puijenbroek E. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands. Drug Saf 2012;35(3):221-31
    • (2012) Drug Saf , vol.35 , Issue.3 , pp. 221-231
    • Oosterhuis, I.1    Van Hunsel, F.2    Van Puijenbroek, E.3
  • 2
    • 0036968027 scopus 로고    scopus 로고
    • Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting
    • van Grootheest K, Mes K, de Jong-van den Berg L. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pr 2002;10:267-72
    • (2002) Int J Pharm Pr , vol.10 , pp. 267-272
    • Van Grootheest, K.1    Mes, K.2    De Jong-Van Den Berg, L.3
  • 3
    • 34147167675 scopus 로고    scopus 로고
    • Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor
    • Wallerstedt SM, Brunlof G, Johansson ML, et al. Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor. Eur J Clin Pharmacol 2007;63(5):505-8
    • (2007) Eur J Clin Pharmacol , vol.63 , Issue.5 , pp. 505-508
    • Wallerstedt, S.M.1    Brunlof, G.2    Johansson, M.L.3
  • 5
    • 84901921309 scopus 로고    scopus 로고
    • Adverse drug reaction reporting by patients: An overview of fifty countries
    • Margraff F, Bertram D. Adverse drug reaction reporting by patients: an overview of fifty countries. Drug Saf 2014;37(6):409-19
    • (2014) Drug Saf , vol.37 , Issue.6 , pp. 409-419
    • Margraff, F.1    Bertram, D.2
  • 6
    • 83055169901 scopus 로고    scopus 로고
    • Experiences with adverse drug reaction reporting by patients; An 11-country survey
    • van Hunsel F, Härmark L, Pal S, et al. Experiences with adverse drug reaction reporting by patients; An 11-country survey. Drug Saf 2012;35(1):45-60
    • (2012) Drug Saf , vol.35 , Issue.1 , pp. 45-60
    • Van Hunsel, F.1    Härmark, L.2    Pal, S.3
  • 7
    • 79955148466 scopus 로고    scopus 로고
    • Patient views and experiences of making adverse drug reaction reports to the yellow card scheme in the UK
    • McLernon DJ, Bond CM, Lee AJ, et al. Patient views and experiences of making adverse drug reaction reports to the yellow card scheme in the UK. Pharmacoepidemiol Drug Saf 2011;20(5):523-31
    • (2011) Pharmacoepidemiol Drug Saf , vol.20 , Issue.5 , pp. 523-531
    • McLernon, D.J.1    Bond, C.M.2    Lee, A.J.3
  • 8
    • 78649316137 scopus 로고    scopus 로고
    • Motives for reporting adverse drug reactions by patientreporters in the Netherlands
    • van Hunsel F, van der Welle C, Passier A, et al. Motives for reporting adverse drug reactions by patientreporters in the Netherlands. Eur J Clin Pharmacol 2010;66(11):1143-50
    • (2010) Eur J Clin Pharmacol , vol.66 , Issue.11 , pp. 1143-1150
    • Van Hunsel, F.1    Van Der Welle, C.2    Passier, A.3
  • 9
    • 84928313097 scopus 로고    scopus 로고
    • The European Commission (EM). [Last accessed 10 June 2013]
    • The EU Pharmacogivilance system [online]. The European Commission (EM). [Last accessed 10 June 2013]
    • The EU Pharmacogivilance System [Online]
  • 10
    • 84928311968 scopus 로고    scopus 로고
    • Netherlands pharmacovigilance centre Lareb. Lareb annual report. [Last accessed 3 May 2013]
    • Netherlands pharmacovigilance centre Lareb. Lareb annual report. 2003. Available from: http://www.lareb. nl/getmedia/160a9a1b-b36a-4e07-b0df-abb65384dcac/jaarverslag2003.pdf [Last accessed 3 May 2013]
    • (2003)
  • 11
    • 84928334576 scopus 로고    scopus 로고
    • Netherlands Pharmacovigilance Centre Lareb. Lareb annual report. [Last accessed 3 May 2013]
    • Netherlands Pharmacovigilance Centre Lareb. Lareb annual report. 2010. Available from: http://www.lareb. nl/getmedia/79575982-de61-40cb-8650-67b33f9c78b9/Lareb-jaarbericht-2010.pdf [Last accessed 3 May 2013]
    • (2010)
  • 12
    • 84928339266 scopus 로고    scopus 로고
    • Netherlands Pharmacovigilance Centre Lareb. Lareb annual report. [Last accessed 16 May 2013]
    • Netherlands Pharmacovigilance Centre Lareb. Lareb annual report. 2012. Available from: http://www.lareb. nl/getmedia/61b4572b-2922-4ed2-b4ae-b1c21bca060d/Jaarbericht-2012.pdf [Last accessed 16 May 2013]
    • (2012)
  • 13
    • 84928309708 scopus 로고    scopus 로고
    • Current Challenges in Pharmacovigilance: Pragmatic Approaches, III Good case management practives, Criteria for seriousness
    • CIOMS Working Groups V. Switzerland.
    • CIOMS Working Groups V. Current Challenges in Pharmacovigilance: Pragmatic Approaches, III Good case management practives, Criteria for seriousness. Council for Internaitonal Organizations of Medical Sciences (CIOMS), Switzerland. 2001;99-100
    • (2001) Council for Internaitonal Organizations of Medical Sciences (CIOMS) , pp. 99-100
  • 14
    • 84872519497 scopus 로고    scopus 로고
    • [Last accessed 30 July 2012]
    • Survey Monkey. Available from: http://www.surveymonckey.com [Last accessed 30 July 2012]
    • Survey Monkey
  • 15
    • 84936823737 scopus 로고
    • Regression models with ordinal variables
    • Winship C, Mare RD. Regression models with ordinal variables. Am Socialog Rev 1984;49:512-25
    • (1984) Am Socialog Rev , vol.49 , pp. 512-525
    • Winship, C.1    Mare, R.D.2
  • 16
    • 84928334561 scopus 로고    scopus 로고
    • Last accessed 12 September 2011]
    • The Central Committee on Research Involving Human Subjects (CCMO). Guideline CCMO. Available from: http://www.ccmo-online.nl/main.asp?pid=1&taal= [Last accessed 12 September 2011]
    • Guideline CCMO
  • 17
    • 40949147823 scopus 로고    scopus 로고
    • The qualitative content analysis process
    • Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs 2007;62(1):107-15
    • (2007) J Adv Nurs , vol.62 , Issue.1 , pp. 107-115
    • Elo, S.1    Kyngäs, H.2
  • 18
    • 84890342084 scopus 로고    scopus 로고
    • Patient-reported outcome measures in safety event reporting: Prosper consortium guidance
    • Banerjee AK, Okun S, Edwards IR, et al. Patient-reported outcome measures in safety event reporting: prosper consortium guidance. Drug Saf 2013;36(12):1129-49
    • (2013) Drug Saf , vol.36 , Issue.12 , pp. 1129-1149
    • Banerjee, A.K.1    Okun, S.2    Edwards, I.R.3
  • 19
    • 84928324961 scopus 로고    scopus 로고
    • Statistics Netherlands [Last accessed 17 May 2013]
    • Statistics Netherlands. Available from: www.cbs.nl [Last accessed 17 May 2013]
  • 20
    • 84928348349 scopus 로고    scopus 로고
    • Dutch Ministry of Education Culture and Science Level of education of Dutch population [Last accessed 1 July 2013]
    • Dutch Ministry of Education Culture and Science Level of education of Dutch population. Available from: http://www.trendsinbeeld.minocw.nl/grafieken/3-1-2-31.php [Last accessed 1 July 2013]


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.